1. Home
  2. WEYS vs LRMR Comparison

WEYS vs LRMR Comparison

Compare WEYS & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEYS
  • LRMR
  • Stock Information
  • Founded
  • WEYS 1906
  • LRMR N/A
  • Country
  • WEYS United States
  • LRMR United States
  • Employees
  • WEYS N/A
  • LRMR N/A
  • Industry
  • WEYS Apparel
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEYS Consumer Staples
  • LRMR Health Care
  • Exchange
  • WEYS Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • WEYS 294.5M
  • LRMR 309.8M
  • IPO Year
  • WEYS N/A
  • LRMR N/A
  • Fundamental
  • Price
  • WEYS $28.92
  • LRMR $4.82
  • Analyst Decision
  • WEYS
  • LRMR Strong Buy
  • Analyst Count
  • WEYS 0
  • LRMR 7
  • Target Price
  • WEYS N/A
  • LRMR $16.71
  • AVG Volume (30 Days)
  • WEYS 14.3K
  • LRMR 4.7M
  • Earning Date
  • WEYS 11-04-2025
  • LRMR 10-29-2025
  • Dividend Yield
  • WEYS 3.73%
  • LRMR N/A
  • EPS Growth
  • WEYS N/A
  • LRMR N/A
  • EPS
  • WEYS 2.69
  • LRMR N/A
  • Revenue
  • WEYS $281,051,000.00
  • LRMR N/A
  • Revenue This Year
  • WEYS N/A
  • LRMR N/A
  • Revenue Next Year
  • WEYS N/A
  • LRMR N/A
  • P/E Ratio
  • WEYS $10.65
  • LRMR N/A
  • Revenue Growth
  • WEYS N/A
  • LRMR N/A
  • 52 Week Low
  • WEYS $25.51
  • LRMR $1.61
  • 52 Week High
  • WEYS $41.05
  • LRMR $9.50
  • Technical
  • Relative Strength Index (RSI)
  • WEYS 38.70
  • LRMR 57.10
  • Support Level
  • WEYS $29.61
  • LRMR $4.52
  • Resistance Level
  • WEYS $30.41
  • LRMR $4.99
  • Average True Range (ATR)
  • WEYS 0.80
  • LRMR 0.52
  • MACD
  • WEYS -0.11
  • LRMR 0.04
  • Stochastic Oscillator
  • WEYS 0.00
  • LRMR 73.57

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: